Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Tirzepatide Once Weekly versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-ADOLESCENTS-2)

Project: Research

Project Details

StatusActive
Effective start/end date04/8/2409/30/27

Funding

  • Lilly USA LLC: $77,235.53